Research transparency promotion by surgical journals publishing randomised controlled trials: a survey.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
01 Oct 2020
Historique:
received: 27 09 2019
accepted: 22 09 2020
entrez: 2 10 2020
pubmed: 3 10 2020
medline: 22 6 2021
Statut: epublish

Résumé

To describe surgical journals' position statements on data-sharing policies (primary objective) and to describe key features of their research transparency promotion. Only "SURGICAL" journals with an impact factor higher than 2 (Web of Science) were eligible for the study. They were included, if there were explicit instructions for clinical trial publication in the official instructions for authors (OIA) or if they had published randomised controlled trial (RCT) between 1 January 2016 and 31 December 2018. The primary outcome was the existence of a data-sharing policy included in the instructions for authors. Data-sharing policies were grouped into 3 categories, inclusion of data-sharing policy mandatory, optional, or not available. Details on research transparency promotion were also collected, namely the existence of a "prospective registration of clinical trials requirement policy", a conflict of interests (COIs) disclosure requirement, and a specific reference to reporting guidelines, such as CONSORT for RCT. Among the 87 surgical journals identified, 82 were included in the study: 67 (82%) had explicit instructions for RCT and the remaining 15 (18%) had published at least one RCT. The median impact factor was 2.98 [IQR = 2.48-3.77], and in 2016 and 2017, the journals published a median of 11.5 RCT [IQR = 5-20.75]. The OIA of four journals (5%) stated that the inclusion of a data-sharing statement was mandatory, optional in 45% (n = 37), and not included in 50% (n = 41). No association was found between journal characteristics and the existence of data-sharing policies (mandatory or optional). A "prospective registration of clinical trials requirement" was associated with International Committee of Medical Journal Editors (ICMJE) allusion or affiliation and higher impact factors. Journals with specific RCT instructions in their OIA and journals referenced on the ICMJE website more frequently mandated the use of CONSORT guidelines. Research transparency promotion is still limited in surgical journals. Standardisation of journal requirements according to ICMJE guidelines could be a first step forward for research transparency promotion in surgery.

Identifiants

pubmed: 33004055
doi: 10.1186/s13063-020-04756-7
pii: 10.1186/s13063-020-04756-7
pmc: PMC7528240
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

824

Références

BMJ. 2018 Feb 13;360:k400
pubmed: 29440066
Eur J Clin Invest. 2019 Sep;49(9):e13151
pubmed: 31206647
Ann Intern Med. 1993 Apr 15;118(8):646-7
pubmed: 8452334
JAMA Surg. 2018 Nov 1;153(11):997-1002
pubmed: 30140910
N Engl J Med. 2004 Sep 16;351(12):1250-1
pubmed: 15356289
Lancet. 2014 Jan 11;383(9912):101-4
pubmed: 24411643
Science. 2015 Jun 26;348(6242):1422-5
pubmed: 26113702
JAMA. 2016 Mar 22-29;315(12):1237-9
pubmed: 27002444
N Engl J Med. 2017 Jun 8;376(23):2277-2279
pubmed: 28581902
Ann Surg. 2019 Mar;269(3):e25-e27
pubmed: 29266005
PLoS One. 2017 Apr 17;12(4):e0175583
pubmed: 28414751

Auteurs

N Lombard (N)

Department of HPB and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France.
Rennes 1 University, Rennes, France.

A Gasmi (A)

Department of HPB and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France.
Rennes 1 University, Rennes, France.

L Sulpice (L)

Department of HPB and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France.
Rennes 1 University, Rennes, France.
Institut NuMeCan (Nutrition Metabolism and Cancer), INSERM 1241, F-35000, Rennes, France.
Univ Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], F-35000, Rennes, France.

K Boudjema (K)

Department of HPB and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France.
Rennes 1 University, Rennes, France.
Institut NuMeCan (Nutrition Metabolism and Cancer), INSERM 1241, F-35000, Rennes, France.
Univ Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], F-35000, Rennes, France.

F Naudet (F)

Rennes 1 University, Rennes, France.
Univ Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d'Investigation Clinique de Rennes)], F-35000, Rennes, France.

D Bergeat (D)

Department of HPB and Digestive Surgery, CHU Rennes, Pontchaillou Hospital, Rennes, France. damien.bergeat@chu-rennes.fr.
Rennes 1 University, Rennes, France. damien.bergeat@chu-rennes.fr.
Institut NuMeCan (Nutrition Metabolism and Cancer), INSERM 1241, F-35000, Rennes, France. damien.bergeat@chu-rennes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH